Skip to main content
Premium Trial:

Request an Annual Quote

Spartan Bio Donates PCR-based Analyzers to Canadian Hospitals

NEW YORK (GenomeWeb News) — Spartan Bioscience said today that it has donated two of its DNA analyzers to Canadian hospitals for non-batched “stat” testing on specimens that are rushed outside of virology labs.
The Ottawa-based company said it has donated one of its Spartan DX real-time PCR DNA analyzers to the Children’s Hospital of Eastern Ontario and another to the Ottawa Hospital.
Spartan Bioscience’s founder, Paul Lem, said in a statement that the company is seeking “input and guidance from researchers in the field” to help it develop more applications for its technology.
CHEO clinical virologist Tim Karnauchow said the hospital has worked with Spartan Bioscience to develop a test for herpes simplex virus and it is currently working with the company on a test for enterovirus.
Karam Ramotar, a molecular microbiologist at the Ottawa Hospital, said the Spartan tool is “ideal for use in diagnostic laboratories to develop assays that, in the future, may be used for clinical diagnostic purposes.”
Spartan Bioscience, a privately held company, was founded in 2005.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.